Bio-Rad Laboratories Inc (BIO)
325.58
+1.89
(+0.58%)
USD |
NYSE |
Nov 21, 16:00
327.10
+1.52
(+0.47%)
Pre-Market: 09:28
Bio-Rad Laboratories Enterprise Value: 8.694B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 8.694B |
| November 20, 2024 | 8.641B |
| November 19, 2024 | 8.556B |
| November 18, 2024 | 8.346B |
| November 15, 2024 | 8.547B |
| November 14, 2024 | 9.384B |
| November 13, 2024 | 9.747B |
| November 12, 2024 | 9.785B |
| November 11, 2024 | 9.824B |
| November 08, 2024 | 9.917B |
| November 07, 2024 | 10.02B |
| November 06, 2024 | 10.02B |
| November 05, 2024 | 10.06B |
| November 04, 2024 | 9.907B |
| November 01, 2024 | 9.893B |
| October 31, 2024 | 9.607B |
| October 30, 2024 | 8.834B |
| October 29, 2024 | 8.864B |
| October 28, 2024 | 8.778B |
| October 25, 2024 | 8.544B |
| October 24, 2024 | 8.764B |
| October 23, 2024 | 8.960B |
| October 22, 2024 | 9.093B |
| October 21, 2024 | 9.185B |
| October 18, 2024 | 9.276B |
| Date | Value |
|---|---|
| October 17, 2024 | 9.209B |
| October 16, 2024 | 8.812B |
| October 15, 2024 | 9.158B |
| October 14, 2024 | 9.127B |
| October 11, 2024 | 9.011B |
| October 10, 2024 | 8.913B |
| October 09, 2024 | 9.059B |
| October 08, 2024 | 9.076B |
| October 07, 2024 | 9.126B |
| October 04, 2024 | 9.201B |
| October 03, 2024 | 9.016B |
| October 02, 2024 | 9.171B |
| October 01, 2024 | 9.033B |
| September 30, 2024 | 8.946B |
| September 27, 2024 | 8.821B |
| September 26, 2024 | 8.830B |
| September 25, 2024 | 8.369B |
| September 24, 2024 | 8.713B |
| September 23, 2024 | 8.677B |
| September 20, 2024 | 8.772B |
| September 19, 2024 | 9.178B |
| September 18, 2024 | 9.063B |
| September 17, 2024 | 8.874B |
| September 16, 2024 | 8.779B |
| September 13, 2024 | 8.666B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
7.018B
Minimum
Jul 01 2024
23.43B
Maximum
Sep 02 2021
13.27B
Average
13.04B
Median
Feb 15 2023
Enterprise Value Benchmarks
| Agilent Technologies Inc | 39.10B |
| Bruker Corp | 10.71B |
| Azenta Inc | 1.613B |
| Harvard Bioscience Inc | 127.50M |
| Bionano Genomics Inc | 14.35M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 653.17M |
| Revenue (Quarterly) | 649.73M |
| Total Expenses (Quarterly) | 585.26M |
| EPS Diluted (Quarterly) | 23.34 |
| Gross Profit Margin (Quarterly) | 54.78% |
| Earnings Yield | -8.39% |
| Operating Earnings Yield | 3.31% |
| Normalized Earnings Yield | 2.897 |